Founded in Rehovot, Israel with offices in New York City, Todos Medical Ltd. (OTCQB: TOMDF) engineers diagnostic testing solutions for the immune system: COVID, Cancer & Alzheimer’s.

Lab Solutions: Our focus on automation has created a commercial infrastructure able to deploy integrated solutions for labs looking to scale services for their core clients.

R&D Pipeline: Evidence suggests that blood-based tests are the future of cancer screening. Our TBIA platform represents a cost-effective, scalable, and patient-friendly screening practice for cancer detection. Videssa® Breast: Cancer Blood Test | LymPro™: Alzheimer's Blood Test | TolloTest™: 3CL Protease Test | TBIA: AI Cancer Platform

Protease Inhibitors: Todos has acquired exclusive distribution rights to the immune boosting, dietary supplement Tollovid™ and is developing Tollovir™, a highly potent 3CL protease inhibitor as a COVID-19 antiviral.

For more information, please visit www.todosmedical.com/.